- Home
- ALLR vs ATCH Comparison
ALLR vs ATCH Comparison
Compare ALLR & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- ATCH
- Stock Information
- Founded
- ALLR 2004
- ATCH 2022
- Country
- ALLR United States
- ATCH United States
- Employees
- ALLR N/A
- ATCH N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- ALLR Health Care
- ATCH
- Exchange
- ALLR Nasdaq
- ATCH Nasdaq
- Market Cap
- ALLR 15.8M
- ATCH 2.5M
- IPO Year
- ALLR N/A
- ATCH N/A
- Fundamental
- Price
- ALLR $0.94
- ATCH $0.19
- Analyst Decision
- ALLR Strong Buy
- ATCH
- Analyst Count
- ALLR 1
- ATCH 0
- Target Price
- ALLR $9.00
- ATCH N/A
- AVG Volume (30 Days)
- ALLR 367.8K
- ATCH 33.6M
- Earning Date
- ALLR 08-15-2025
- ATCH 09-02-2025
- Dividend Yield
- ALLR N/A
- ATCH N/A
- EPS Growth
- ALLR N/A
- ATCH N/A
- EPS
- ALLR N/A
- ATCH N/A
- Revenue
- ALLR N/A
- ATCH $14,825,966.00
- Revenue This Year
- ALLR N/A
- ATCH N/A
- Revenue Next Year
- ALLR N/A
- ATCH N/A
- P/E Ratio
- ALLR N/A
- ATCH N/A
- Revenue Growth
- ALLR N/A
- ATCH 1066.77
- 52 Week Low
- ALLR $0.61
- ATCH $0.14
- 52 Week High
- ALLR $6.00
- ATCH $26.94
- Technical
- Relative Strength Index (RSI)
- ALLR 47.03
- ATCH 49.97
- Support Level
- ALLR $0.85
- ATCH $0.17
- Resistance Level
- ALLR $1.01
- ATCH $0.25
- Average True Range (ATR)
- ALLR 0.05
- ATCH 0.03
- MACD
- ALLR -0.01
- ATCH 0.00
- Stochastic Oscillator
- ALLR 47.55
- ATCH 39.28
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.